Alphatec Holdings Chairman and CEO Pat Miles discussed the company's performance over the past year during his third quarter conference call, as well as new innovations for the future.
Here are five quotes from Mr. Miles from the call, as transcribed by Seeking Alpha:
Pat Miles on adding to biologics: "Over the past decade, the industry's leading innovators have been the pure-play spine companies. Their focused commitment has been rewarded with revenue growth that has exceeded the broader market. The team that drove much of that innovation now resides with Alphatec. We continue to add profound spine experience with the employment of Mark Ojeda to lead our cervical and biologics efforts."
PM on expanding OR capabilities within Alphatec's platform: "Surgeons yearn for interoperative information that will drive better decision-making. Other market players are addressing that need with robotics and capital equipment that demand huge physical footprints in the OR, an already severely limited space. Our answer is Alpha Informatics, a small Bluetooth-enabled platform that will deliver better, more relevant, real-time information."
"We are developing next-generation access systems, implants and biologics that we'll seamlessly integrate into Alpha Informatics to enable elegant, minimally disruptive solutions regardless of approach. The first future set of Alpha Informatics will be advanced, automated neuromonitoring powered by SafeOp, which we submitted to the FDA during the third quarter."
PM on how Alphatec's revenue driver will change: "Over 80 percent of our revenue is generated by products that were developed and launched in or before 2016. We expect that mix to shift going forward as we bring next-generation products to market. That starts with 12 Alpha launches on track to be delivered in 2018."
PM on 2019 product releases: "Looking forward to 2019 and beyond, we intend to lead the industry in innovation by releasing eight to 10 new products each year."